Market capitalization | $880.00k |
Enterprise Value | $5.74m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.43 |
P/S ratio (TTM) P/S ratio | 0.07 |
P/B ratio (TTM) P/B ratio | 0.07 |
Revenue growth (TTM) Revenue growth | 5.75% |
Revenue (TTM) Revenue | $13.29m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
Aug '24 |
+/-
%
|
||
Revenue | 13 13 |
6%
6%
|
|
Gross Profit | 5.74 5.74 |
66%
66%
|
|
EBITDA | -6.05 -6.05 |
7%
7%
|
EBIT (Operating Income) EBIT | -8.31 -8.31 |
3%
3%
|
Net Profit | -16 -16 |
22%
22%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.
Head office | United States |
CEO | Robert Mattacchione |
Employees | 264 |
Founded | 2000 |
Website | novointegrated.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.